Clotting linked with Covid vaccine very rare, new study confirms

The very rare blood clots that can be caused by the Oxford/AstraZeneca coronavirus vaccine can be aggressive and deadly but is very rare, leading scientists have concluded in the findings of the first study of its kind on Thursday.

The very rare blood clots that can be caused by the Oxford/AstraZeneca coronavirus vaccine can be aggressive and deadly but is very rare, leading scientists have concluded in the findings of the first study of its kind on Thursday. A research team led by Dr Sue Pavord of the Oxford University Hospitals NHS Foundation Trust examined vaccine-induced immune thrombocytopenia and thrombosis (VITT).